Ann: RELINT: FPH: Disclosure of Directors and Off

• Release Date: 11/07/12 15:52
• Summary: RELINT: FPH: Disclosure of Directors and Officer Relevant Interests
• Price Sensitive: No
• Download Document  4.15KB

					

FPH
11/07/2012 13:52
RELINT

REL: 1352 HRS Fisher & Paykel Healthcare Corporation Limited

RELINT: FPH: Disclosure of Directors and Officer Relevant Interests

Name of director or officer of public issuer:  Antony John CARTER
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable):  Not Applicable
Position held in public issuer:  Director

B Securities in public issuer or any related body corporate in which director
or officer has relevant interest
Number, class, and type of securities:   "(i) 150 Ordinary Shares
(ii) 1,983 Ordinary Shares"

C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities:   Beneficial
Name of registered holder of securities   "(i) Antony Carter Family Trust No
2
(ii) Loughborough Investments Limited"

D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition:   6 July 2012
Consideration paid for acquisition:   "(i) NZ$284.25
(ii) NZ$3,757.79"

If the relevant interest was disposed of--
Date of disposal:   Not Applicable
Consideration paid for disposal:   Not Applicable

Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition took place:   "(i) Purchase of 150 Ordinary Shares under the
Dividend Reinvestment Plan;
(ii) Purchase of 1,983 Ordinary Shares under the Dividend Reinvestment Plan."

E Total number of transactions this notice relates to:  Two

F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer:   9 February 2012

Name of director or officer of public issuer:  Nigel Thomas EVANS
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable):  Not Applicable
Position held in public issuer:  Director

B Securities in public issuer or any related body corporate in which director
or officer has relevant interest
Number, class, and type of securities:   691 Ordinary Shares

C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities:   Beneficial Ownership
Name of registered holder of securities   Nigel Thomas EVANS and Janette
Elizabeth EVANS

D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition:   6 July 2012
Consideration paid for acquisition:   $1,309.45

If the relevant interest was disposed of--
Date of disposal:   Not Applicable
Consideration paid for disposal:   Not Applicable

Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition took place:   Purchase of 691 Ordinary Shares under the
Dividend Reinvestment Plan

E Total number of transactions this notice relates to:  One

F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer:   22 December 2011

Name of director or officer of public issuer:  Antony George BARCLAY
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable):  Not Applicable
Position held in public issuer:  Chief Financial Officer & Company Secretary

B Securities in public issuer or related body corporate to which this
disclosure relates
Number, class, and type of securities:   1,185 Ordinary shares

C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities:   Non-Beneficial Ownership
Name of registered holder of securities   Antony George BARCLAY

D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition:   6 July 2012
Consideration paid for acquisition   $2,245.58

If the relevant interest was disposed of--
Date of disposal:   N/A
Consideration received from disposal: N/A

Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the issue & transfer took place:   Purchase of 1,185 Ordinary shares under
the Dividend Reinvestment Plan

E Total number of transactions this notice relates to:  One

F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer:   22 December 2012
End CA:00224844 For:FPH    Type:RELINT     Time:2012-07-11 13:52:51